AddedRisk Factors
Our Credit Agreement contains several negative covenants that limit our ability to: consummate certain mergers, consolidations and dissolutions; sell assets; consummate certain investments and acquisitions; incur indebtedness; grant liens; engage in affiliate transactions; and pay dividends and restricted payments.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedRisk Factors
disagrees with the conclusions in the opinions that are not covered by the private letter ruling, or for other reasons, including as a result of certain significant changes in our stock ownership or the stock ownership of Select following the Distribution.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedRisk Factors
As an independent, publicly traded company, we are required to maintain internal control over financial reporting and to report any material weaknesses in our internal control.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedRisk Factors
issuances and sales of shares of our common stock will have on the market price of shares of our common stock. Any such issuance could result in substantial dilution to our existing stockholders.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RemovedRisk Factors
evaluate such arrangements on a case-by-case basis, taking into account all facts and circumstances, including the parties’ intent and the arrangement’s potential for abuse, and may be subject to greater scrutiny by enforcement agencies;
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
government will continue to devote substantial resources to investigating healthcare providers’ compliance with the FCA and other applicable fraud and abuse laws.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
Inflation has also increased throughout the U.S. economy. In the current inflationary environment, we have and may continue to experience increases in labor costs, supply chain costs, capital expenditures and other costs of doing business. For instance, during the recovery period following the COVID-19 pandemic outbreak in early 2020, we experienced significant staffing shortages. These shortages were driven primarily by higher than historical turnover and lower replacement candidate levels. In 2020, and the subsequent years of 2021 and 2022, we initiated compensation strategies to combat the higher turnover and attract new colleagues. These strategies resulted in salary inflation pressure that was in excess of our normal annual merit increase percentages. We also predominantly lease our occupational health center locations. Since the COVID-19 pandemic in 2020, we have experienced, and continue to experience, higher than normal facility lease renewal increases. Relatedly, construction costs have continued to increase since the COVID-19 pandemic, resulting in longer payback period on our capital investments.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
U.S. and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions and the military conflicts between Russia and Ukraine as well as Israel, Iran and Palestine. Although the length and impact of the ongoing military conflicts is highly unpredictable, such conflicts could lead to market disruptions, including significant
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
volatility in credit and capital markets, as well as supply chain interruptions. We are continuing to monitor the conflicts and assessing their potential impact on our business.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
The ongoing military conflict in Ukraine has led to sanctions and other penalties being levied by the United States, the European Union and various other countries against Russia. Additional sanctions or other measures may be imposed by the global community, and counteractive measures may be taken by the Russian government, other entities in Russia or governments or other entities outside of Russia that could adversely affect the global economy and lead to instability in capital markets. Furthermore, the ongoing conflict involving Israel, Iran and Palestine and the potential destabilization of the Middle East region due to rising geographical tensions may cause additional economic uncertainty, including increased inflation and supply chain disruptions.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
and we may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to service or refinance our debt.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
the Code. See “Certain Relationships and Related Person Transactions — Agreements Entered into in Connection with the Separation — Tax Matters Agreement.”
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
•announcements made or actions taken by Select, whether in respect of the Distribution or otherwise;
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
Our amended and restated certificate of incorporation and our amended and restated bylaws contain provisions that are intended to deter coercive takeover practices and inadequate takeover bids and to encourage prospective acquirers to negotiate
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
We expect that stakeholders will compare our ESG goals and commitments against those of our competitors. Our competitors could have more robust ESG goals and commitments or be more successful at implementing their ESG goals and commitments than us, which could adversely affect our reputation. Our competitors could also decide not to establish ESG goals and commitments at a scope or scale that is comparable to our ESG goals and commitments, which could result in our competitors having lower supply chains or operating costs.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedRisk Factors
Our reputation may be affected by our perceived ESG credentials and our ability to meet our ESG goals. Despite our efforts, any actual or perceived failure to achieve our ESG goals or the perception (whether or not valid) that we have failed to act responsibly with respect to ESG matters, comply with ESG laws or regulations or meet societal, investor and consumer ESG expectations could result in negative publicity and reputational damage, lead consumers or customers to purchase competing products or investors to choose not to invest in our company or cause dissatisfaction among our employees or other stakeholders, which could adversely affect our business, financial condition and results of operations.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RewordedRisk Factors
Notwithstanding the private letter ruling and opinions of tax advisors, the IRS could determine on audit that certain steps of the Separation or the Distribution are taxable if it determines that any of these facts, assumptions, representations or undertakings are not correct or have been violated or if it disagrees with the conclusions in the opinions that are not covered by the private letter ruling, or for other reasons, including as a result of certain significant changes in our stock ownership or the stock ownership of Select following the Distribution.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
If we We have adverse changes to our strong and longstanding relationships with our significant major employer customers, third-party payors, workers’ compensation provider networks or and third-party employer services networks, our business, financial condition and results of operations may be adversely affected. networks.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
A continued economic downturn or recession, or slowing or stalled recovery therefrom, may have a material adverse effect on our business, financial condition and results of operations, as it could negatively impact our current and prospective customers, adversely affect the financial ability of payors to pay claims, adversely impact our ability to pay our expenses and limit our ability to obtain financing for our operations.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
We are currently operating in a period of economic uncertainty and capital markets disruption, which has been significantly impacted by geopolitical instability due to ongoing conflicts in the ongoing Israel-Palestine Middle East and Russia-Ukraine military conflicts. Russia and Ukraine and tensions between the United States and China and the United States and Venezuela.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our cash flow from operations may not be sufficient to service our outstanding debt or to repay the outstanding debt as it becomes due, and we may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to service or refinance our debt.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
Implementing any necessary enhancements to our global processes and controls to reflect the increased scrutiny and rapidly evolving expectations regarding ESG matters may be complex, time-consuming, and costly. costly, and we may fail to meet our ESG goals, or fall short of the ESG achievements of our competitors.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
We cannot predict with certainty the size of future issuances of shares of our common stock or the effect, if any, that future issuances and sales of shares of our common stock will have on the market price of shares of our common stock.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
If a successful legal challenge or an adverse change in relevant laws were to occur, and we were unable to adapt our business model accordingly, our operations in affected jurisdictions would be disrupted, which could harm our business.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition to the other information in this annual report Annual Report on Form 10-K, you should consider carefully the factors set forth below before making an investment decision to purchase shares of our common stock. below.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
If known or unknown risks or uncertainties materialize, our business, financial condition and results of operations could be adversely affected, potentially in a material way, which could result in a partial or complete loss cause the trading price of your investment. our common stock to decline.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
If we are unable to obtain a waiver from the requisite lenders under such circumstances, these the lenders could exercise their rights, then which could adversely affect our financial condition and results of operations could be adversely affected, and we could become result in us becoming bankrupt or insolvent.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
Legislators and regulators have imposed, and likely will may continue to impose, ESG-related legislation, rules, and guidance, which may conflict with one another, create new disclosure obligations, result in additional compliance costs, or expose us to new or additional risks.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
However, cost Cost increases due to inflationary pressures may outpace our expectations and we may not be able to offset the higher costs through price increases and achieve cost efficiencies, causing us to use our cash and other liquid assets faster than forecasted.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
You should read this discussion together with the consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. As discussed in the section titled “Forward-Looking Statements,” the following discussion and analysis contains forward-looking statements that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, those identified below and those discussed in the section titled “Risk Factors” in Part I, Item 1A of this Annual Report on Form 10-K.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Pivot Onsite Innovations operated over 240 onsite health clinics at employer locations in over 40 states, providing occupational health, wellness, prevention, and performance services. The acquisition enabled the Company to expand to over 400 onsite health clinics at employer worksites.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
During the year ended December 31, 2025, the Company made voluntary repayments on the Revolving Credit Facility of $85 million, which resulted in no borrowings outstanding on the Revolving Credit Facility as of December 31, 2025. These repayments were made using available cash on hand and were not contractually required. Under the terms of the Credit Agreement, repayment was not due until July 26, 2029.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
During the year ended December 31, 2025, we repurchased 1.1 million shares of our common stock for $22.4 million. The repurchase of common stock included shares repurchased under the share repurchase program and 114,052 shares of common stock repurchased for $2.4 million related to the shares withheld in connection with the vesting of employee restricted stock awards. Shares repurchased in connection with employee restricted stock awards do not impact the remaining authorization under the share repurchase program.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
On November 5, 2025, the Board of Directors authorized a share repurchase program to repurchase up to $100 million of the Company’s outstanding common stock. The share repurchase program will expire on December 31, 2027, unless extended or terminated by the Board of Directors. Stock repurchases under this program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as the Board of Directors deems appropriate. The Company will fund the share repurchase program with cash on hand. The authorization of the share repurchase program does not obligate the Company to repurchase any shares.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
During the year ended December 31, 2025, the Company repurchased 1.0 million shares of common stock under the share repurchase program for $20.0 million. All shares repurchased were permanently retired. As of December 31, 2025, the Company’s remaining authorization to repurchase shares under the program was $80.0 million.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
(1) Adjusted EBITDA and Adjusted Net Income Attributable to the Company are financial measures not calculated in accordance with U.S. GAAP. For definitions and reconciliations to the U.S. GAAP measures, please see “—Non-GAAP Measures”.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Revenue increased 13.9% to $2,163.4 million for the year ended December 31, 2025, compared to $1,900.2 million for the year ended December 31, 2024, driven by organic increases in both volume of patient visits and revenue per visit and due to the addition of 72 occupational health centers that were acquired through acquisitions in March 2025 and over 240 onsite locations that were acquired through acquisition in June 2025.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
flow loss combined with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
(1) The percentage of revenue values on this row represent the net income margin for the period.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
(3) The percentage of revenue values on this row represent the Adjusted EBITDA margin for the period.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Adjusted Net Income Attributable to the Company and Adjusted Earnings per Share are used by management to provide useful insight into the underlying performance of our business. Adjusted Net Income Attributable to the Company and Adjusted Earnings per Share are not measures of financial performance under U.S. GAAP and are not intended to be substitutes for U.S. GAAP measures such as net income attributable to the Company or earnings per share. These metrics may differ from similarly titled metrics supported by other companies. Other companies, including companies in our industry, may calculate Adjusted Net Income Attributable to the Company and Adjusted Earnings per Share differently than we do, limiting the usefulness of those measures for comparative purposes. Concentra believes that the presentation of Adjusted Net Income Attributable to the Company and Adjusted Earnings per Share are important to investors because they are reflective of the financial performance of Concentra’s ongoing operations and provide better comparability of its results of operations between periods. Investors should consider these measures in addition to, and not as a replacement for, U.S. GAAP results reported in our financial statements.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RemovedMD&A
You should read this discussion together with the consolidated financial statements and related notes included elsewhere in this Annual Report.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedMD&A
On January 3, 2024, Select Medical Holdings Corporation (“Select”), our former parent company, announced its intention to separate Concentra from its business. In connection with the Separation, we entered into the Separation Agreement, as further described in the section of this annual report on Form 10-K entitled “Certain Relationships and Related Person Transactions — Agreements to be Entered into in Connection with the Separation—Separation Agreement.” We entered into various other agreements with Select and its wholly-owned subsidiaries that, together with the Separation Agreement, provide for certain transactions and arrangements to effect the separation of our business from Select. We refer to these transactions, as further described in the section of this annual report on Form 10-K entitled “The Separation and Distribution Transactions — The Separation,” collectively as the “Separation.”
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedMD&A
On July 26, 2024, the Company completed an Initial Public Offering (“IPO”) of 22,500,000 shares of its common stock, par value $0.01 per share, at an initial public offering price of $23.50 per share for net proceeds of $499.7 million after deducting underwriting discounts and commission of $29.1 million. In addition, the underwriters exercised the option to purchase an additional 750,000 shares of the Company’s common stock for net proceeds of $16.7 million after deducting underwriting discounts and commission of $1.0 million. The Company’s shares began trading on the New York Stock Exchange under the symbol “CON” on July 25, 2024. In connection with the IPO, Concentra Health Services, Inc. (“CHSI”), entered into certain financing arrangements which include the credit facilities of $1,250.0 million (the “Credit Facilities”) and a private offering of $650.0 million aggregate principal amount of 6.875% Senior Notes due 2032 (the “Notes”). The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by Concentra and certain of its wholly-owned subsidiaries. The Credit Facilities consist of the term loan of $850.0 million (the “Term Loan”) and the revolving credit facility of $400.0 million. The Term Loan matures on July 26, 2031, and has an interest rate of Term SOFR plus 2.25%, subject to a leverage-based pricing grid. The revolving credit facility matures on July 26, 2029, and has an interest rate of Term SOFR plus 2.50%, subject to a leverage-based pricing grid.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedMD&A
The net proceeds of the IPO and the debt financing transactions, except for $34.7 million, were paid to Select Medical Corporation (“SMC”) through the issuance of a dividend, the repayment in full of the $420.0 million revolving promissory note outstanding, and the repayment in full of a new promissory note issued subsequent in contemplation of the IPO.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedMD&A
On November 25, 2024, Select completed the special stock distribution consisting of an aggregate 104,093,503 shares of Concentra to Select’s stockholders. As a result, Select no longer owns any shares of Concentra common stock.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RemovedMD&A
We have recorded total goodwill of $1,234.7 million at December 31, 2024, of which $1,146.8 million related to our centers reporting unit, $50.9 million related to our onsites reporting unit, and $36.9 million related to our other businesses reporting unit.
Read it in 10-K Mar 3, 2025 at sec.govopen_in_new
RewordedMD&A
For discussion of our 2022 the year ended December 31, 2023 items and year-to-year comparisons between the years ended December 31, 2024 and December 31, 2023 and 2022 that are not included in this Annual Report on Form 10-K, refer to “Management’s Item 7—“Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s registration statement Annual Report on Form S-1, as amended (File No. 333-280242) (the “Registration Statement”), 10-K, that was filed with the Securities and Exchange Commission on July 24, 2024. March 3, 2025.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
The increase in interest expense was due to the issuance of an $850.0 million term loan and loan, $650.0 million senior notes in late July 2024, $102.1 million of incremental term loan in March 2025, and the $85.0 million in borrowings on the Revolving Credit Facility during the year, which were fully repaid by October 2025, as described in Note 9—“Long-Term Debt” of the notes to our consolidated financial statements. Debt”.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
The increase in cash flows from operating activities for the year ended December 31, 2024, 2025, as compared to the year ended December 31, 2023, 2024, was principally due to an increase in our operating income, partially offset by a decrease from the change in working capital, partially offset by a decrease capital and an increase in our operating income. interest payments following the recapitalization of debt in July 2024.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
Our general and administrative expenses were expense was $203.3 million, or 9.4% of revenue, for the year ended December 31, 2025, compared to $156.3 million, or 8.2% of revenue, for the year ended December 31, 2024, compared to $152.0 million, or 8.3% of revenue, for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
Revenue per visit for workers’ compensation visits increased 2.6% 5.3% to $210.15 from $199.53 from $194.48, and revenue per visit for employer services visits increased 4.5% 2.7% to $90.36 $92.84 from $86.44 and revenue per visit for consumer health visits increased 2.0% to $135.41 from $132.80, $90.36, for the year ended December 31, 2024 as 2025, compared to the year ended December 31, 2023. 2024.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
Cost of services was $1,550.3 million, or 71.7% of revenue, for the year ended December 31, 2025, compared to $1,372.2 million, or 72.2% of revenue, for the year ended December 31, 2024, compared to $1,325.6 million, or 72.1% of revenue, for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
The increase decrease in the net working capital surplus was principally due to an increase a decrease in our cash, which resulted from debt raised during the year Nova acquisition in March 2025, Pivot Onsite Innovations acquisition in June 2025, voluntary revolver repayments, and IPO proceeds we received. share repurchases.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
We define Adjusted EBITDA as earnings excluding net income before, interest, income taxes, depreciation and amortization, gain (loss) stock compensation expense, acquisition related costs, gains or losses on early retirement of debt, stock compensation expense, separation transaction costs, acquisition costs, gain (loss) on sale of businesses, and equity in earnings (losses) or losses of unconsolidated subsidiaries.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
These events or conditions could include a significant change in the business environment, the regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
We had net working capital of $45.9 million at December 31, 2025, compared to net working capital of $130.0 million at December 31, 2024, compared to net working capital of $19.8 million at December 31, 2023. 2024.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
For the year ended December 31, 2024, 2025, the increase decrease in effective tax rate was driven primarily by an unfavorable a favorable tax rate impact associated with stock compensation, an increase in non-deductible compensation increased deduction of covered employees, tax credits and an increase a decrease in the state tax rate.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
Workers’ compensation laws and regulations vary by state, so the specific details of coverage and reimbursement will differ based on the location of the workplace and the laws that govern workers’ compensation in that state and may also differ based on contractual terms with the payor, third-party administrator, or employer. applicable laws.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new